Ardent Health Partners, Inc. ARDT
We take great care to ensure that the data presented and summarized in this overview for Ardent Health Partners, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ARDT
Top Purchases
Top Sells
About ARDT
Insider Transactions at ARDT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2025
|
Robert De Michiei Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,073
+50.0%
|
-
|
|
Apr 01
2025
|
Dave Caspers Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,768
+48.17%
|
-
|
|
Apr 01
2025
|
Dave Caspers Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,480
-32.16%
|
$29,760
$12.97 P/Share
|
|
Apr 01
2025
|
Ethan Chernin President of Health Services |
BUY
Grant, award, or other acquisition
|
Direct |
20,914
+36.75%
|
-
|
|
Apr 01
2025
|
David Raynor Byers SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,565
+9.34%
|
-
|
|
Apr 01
2025
|
David Schultz President Hospital Operations |
BUY
Grant, award, or other acquisition
|
Direct |
26,985
+29.6%
|
-
|
|
Apr 01
2025
|
Alfred Lumsdaine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,971
+20.1%
|
-
|
|
Apr 01
2025
|
Stephen C. Petrovich EVP, GC and Asst. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
22,263
+3.0%
|
-
|
|
Apr 01
2025
|
Martin Bonick President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
134,927
+10.69%
|
-
|
|
Mar 31
2025
|
Ethan Chernin President of Health Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-8.12%
|
$17,316
$13.75 P/Share
|
|
Mar 31
2025
|
David Raynor Byers SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
676
-0.67%
|
$8,788
$13.75 P/Share
|
|
Mar 31
2025
|
David Schultz President Hospital Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,825
-4.68%
|
$23,725
$13.75 P/Share
|
|
Mar 31
2025
|
Alfred Lumsdaine Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,510
-1.54%
|
$32,630
$13.75 P/Share
|
|
Mar 31
2025
|
Stephen C. Petrovich EVP, GC and Asst. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,428
-0.2%
|
$18,564
$13.75 P/Share
|
|
Mar 31
2025
|
Martin Bonick President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,970
-1.29%
|
$168,610
$13.75 P/Share
|
|
Mar 21
2025
|
Peter C B Bynoe Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+11.32%
|
-
|
|
Mar 21
2025
|
Suzanne Campion Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+22.7%
|
-
|
|
Mar 21
2025
|
Ellen Havdala Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+11.32%
|
-
|
|
Mar 21
2025
|
William M Goodyear Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+11.32%
|
-
|
|
Mar 21
2025
|
Mark R Sotir Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+34.54%
|
-
|
Last 12 Months Summary
Buy / Acquisition
584K
Shares
From
17
Insiders
| Grant, award, or other acquisition | 564K shares |
|---|---|
| Open market or private purchase | 20K shares |
Sell / Disposition
23.2K
Shares
From
7
Insiders
| Payment of exercise price or tax liability | 23.2K shares |
|---|